Dr John Attokaren, MD | |
11600 Atlantis Place, Suite B, Alpharetta, GA 30022 | |
(770) 664-4449 | |
(770) 777-6496 |
Full Name | Dr John Attokaren |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 49 Years |
Location | 11600 Atlantis Place, Alpharetta, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831297423 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 29575 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northside Hospital Forsyth | Cumming, GA | Hospital |
Northside Hospital | Atlanta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northside Cardiovascular Professional Services, Llc | 9739189838 | 57 |
News Archive
As the toll of COVID-19 continues to climb, newly released poll data suggest an opportunity to use the pandemic as a prompt for discussing and documenting older adults' wishes for their care, if they get seriously ill or injured for any reason.
It is possible to determine which patients run a high risk of developing Alzheimer's disease and the dementia associated with it, even in patients with minimal memory impairment. This has been shown by recent research at the Sahlgrenska Academy, University of Gothenburg, Sweden.
Researcher Kevin McElwee - one of only a few people in the world who hold a doctoral degree in hair biology - thinks a cure for baldness that uses the technique of hair cloning could be commercially available within 10 years.
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
Those can be some of the most powerful words in the development of any child's ability to read and write.
› Verified 4 days ago
Entity Name | Northside Cardiovascular Professional Services, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518979921 PECOS PAC ID: 9739189838 Enrollment ID: O20070112000232 |
News Archive
As the toll of COVID-19 continues to climb, newly released poll data suggest an opportunity to use the pandemic as a prompt for discussing and documenting older adults' wishes for their care, if they get seriously ill or injured for any reason.
It is possible to determine which patients run a high risk of developing Alzheimer's disease and the dementia associated with it, even in patients with minimal memory impairment. This has been shown by recent research at the Sahlgrenska Academy, University of Gothenburg, Sweden.
Researcher Kevin McElwee - one of only a few people in the world who hold a doctoral degree in hair biology - thinks a cure for baldness that uses the technique of hair cloning could be commercially available within 10 years.
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
Those can be some of the most powerful words in the development of any child's ability to read and write.
› Verified 4 days ago
Entity Name | North Fulton Regional Medical Center Pro Fee Billing, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013142744 PECOS PAC ID: 0345386942 Enrollment ID: O20091013000496 |
News Archive
As the toll of COVID-19 continues to climb, newly released poll data suggest an opportunity to use the pandemic as a prompt for discussing and documenting older adults' wishes for their care, if they get seriously ill or injured for any reason.
It is possible to determine which patients run a high risk of developing Alzheimer's disease and the dementia associated with it, even in patients with minimal memory impairment. This has been shown by recent research at the Sahlgrenska Academy, University of Gothenburg, Sweden.
Researcher Kevin McElwee - one of only a few people in the world who hold a doctoral degree in hair biology - thinks a cure for baldness that uses the technique of hair cloning could be commercially available within 10 years.
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
Those can be some of the most powerful words in the development of any child's ability to read and write.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John Attokaren, MD 11600 Atlantis Place, Suite B, Alpharetta, GA 30022 Ph: (770) 664-4449 | Dr John Attokaren, MD 11600 Atlantis Place, Suite B, Alpharetta, GA 30022 Ph: (770) 664-4449 |
News Archive
As the toll of COVID-19 continues to climb, newly released poll data suggest an opportunity to use the pandemic as a prompt for discussing and documenting older adults' wishes for their care, if they get seriously ill or injured for any reason.
It is possible to determine which patients run a high risk of developing Alzheimer's disease and the dementia associated with it, even in patients with minimal memory impairment. This has been shown by recent research at the Sahlgrenska Academy, University of Gothenburg, Sweden.
Researcher Kevin McElwee - one of only a few people in the world who hold a doctoral degree in hair biology - thinks a cure for baldness that uses the technique of hair cloning could be commercially available within 10 years.
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
Those can be some of the most powerful words in the development of any child's ability to read and write.
› Verified 4 days ago
Jeffrey Obiora, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 | |
Dr. Jay Arthur Cherner, M.D. Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 3330 Preston Ridge Rd, Suite 220, Alpharetta, GA 30005 Phone: 770-410-1600 Fax: 770-410-0006 | |
Randy Turkel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11600 Atlantis Place, Suite B, Alpharetta, GA 30022 Phone: 770-664-4449 Fax: 770-777-6496 | |
Xiaowen Wu, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 10800 Jones Bridge Rd, Ste A, Alpharetta, GA 30022 Phone: 678-867-0135 Fax: 678-867-0137 | |
Dr. Justin Chen, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2575 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 800-930-0748 | |
Irfan Ali Syed, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3584 Old Milton Pkwy, Alpharetta, GA 30005 Phone: 678-691-3388 Fax: 678-395-7702 | |
Arezou Fatemi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy, Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 Fax: 678-205-9005 |